US emergency department use by children, 2001-2010

Irit R Rasooly1, Peter M Mullins, Elizabeth R Alpern

  • 1From the Schools of *Medicine and Health Sciences, and †Public Health and Health Services, The George Washington University, Washington DC; and ‡The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

Pediatric Emergency Care
|August 28, 2014
PubMed

Insights

Pediatric emergency department (ED) visits increased significantly from 2001-2010, with higher rates among Black children and rapid growth in Hispanic children and Medicaid beneficiaries. Care intensity also rose sharply.

Area of Science:

  • Pediatric Emergency Medicine
  • Health Services Research
  • Public Health

Background:

  • Children represent a significant portion of emergency department (ED) utilization.
  • Understanding trends in pediatric ED use is crucial for resource allocation and healthcare planning.

Purpose of the Study:

  • To describe recent trends in US emergency department (ED) use by children.
  • To analyze demographic, clinical, and resource utilization patterns in pediatric ED visits.

Main Methods:

  • Cross-sectional analysis of the National Hospital Ambulatory Medical Care Survey (2001-2010).
  • Inclusion of US Census data for population-based rates.
  • Linear regression to assess the significance of observed trends.

Main Results:

  • Pediatric ED visits increased by 14.4% between 2001 and 2010, outpacing population growth.
  • Trauma was the most frequent reason for visit; Black children had the highest ED visit rates.
  • Hispanic children and Medicaid beneficiaries showed the most significant increases in ED utilization.
  • Resource utilization, including advanced imaging (CT/MRI), diagnostic testing, and medication administration, markedly increased.

Conclusions:

  • Pediatric ED use is rising faster than population growth, indicating increased demand.
  • The intensity of care provided during pediatric ED visits has significantly escalated.
  • Hispanic children and Medicaid beneficiaries are increasingly prominent groups utilizing emergency services.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
399
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
544
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954